Only Medics’ Mobile Website Is Now Live

To further enhance our services we today have launched our new mobile website, offering candidates an easier alternative when searching for their next pharmaceutical physician vacancy using their mobile. With an increasing number of people accessing the internet via their mobiles, Only Medics, as the market-leader and the medical recruitment company of choice for many

Continue Reading

Study Shows Huntington’s Reduces Cancer Risk

According to a study in Sweden, people who have developed Huntington’s disease, a debilitating brain condition, appear have a “protection” from cancer. The findings, which were published in The Lancet Oncology, analysed almost 40 years of medical records, showing that patients with Huntington’s have half the normal expected risk of developing tumours.  However researchers commented

Continue Reading

Eisai Joins Up With Valeant To Promote Halaven

After failing to gain approval from UK cost watchdog, NICE, for the use of Halaven in treating breast cancer, Eisai has linked up with Valeant Pharmaceuticals International, to promote the drug in Central and Eastern Europe. Halaven received European Commission approval in March 2011. Valeant’s PharmaSwiss division will distribute Halaven (eribulin) in Bulgaria, Romania, Latvia,

Continue Reading

UK MPs Approve Controversial NHS Bill

The NHS health bill has survived the final parliamentary test and is set to become law. Labour’s call for MPs to delay their final consideration of the NHS overhaul in England until an evaluation of the potential risks is available was defeated by 82 votes. An emergency debate over the proposed Health and Social Care

Continue Reading